Caplight Directory>Investors>SynBioVen>Synbioven


SynBioVen

SynBioVen

London, Englandsynbioven.com

Overview

SynBioVen is an independent investment vehicle founded in 2022, dedicated to supporting the next generation of synthetic and engineering biology scientists, founders, and start-ups in the United Kingdom. It provides Proof of Concept (PoC), pre-seed, and seed funding, along with technical expertise, strategic mentorship, and access to facilities like the London Biofoundry. The firm focuses on sectors including Life Sciences, High Tech, Environment Tech, healthcare, agriculture, and clean technology.

Portfolio Companies

8

Investments

CompanyDateStageLead
Resurrect bioMay 2026Series ACo-investor
Resurrect bioFeb 2026Series ACo-investor
HotHouse TherapeuticsDec 2025Pre SeedLead
ScindoSep 2025SeedCo-investor
Solena MaterialsMay 2025SeedCo-investor
View all investments

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersLondon, England
Year FoundedN/A

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.